Key facts
- This page summarizes Eric M. Dube's Form 4 filing for Travere Therapeutics, Inc. (TVTX).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Feb 2024, 16:06.
Eric M. Dube - 31 Jan 2024 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- TVTX
- Reported as of
- 31 Jan 2024
- Net transaction value
- -$166,435
- SEC form
- 4
- Accepted by SEC
- 02 Feb 2024, 16:06:01 UTC
- Prior SEC filing
- 25 Jan 2024
- Next SEC filing
- 09 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elizabeth E. Reed, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric M. Dube filed Form 4 for Travere Therapeutics, Inc. (TVTX) on 02 Feb 2024.
Change
- Previous filing in this sequence was filed on 25 Jan 2024.
- Current net transaction value: -$166,435.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TVTX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +135,000
- Change %
- +58%
- Price
- $0.000000
- Shares after
- 369,722
- Date
- 31 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
TVTX
transaction
Common Stock
Sale
- Transaction value
- $77,693
- Shares
- -9,106
- Change %
- -2.5%
- Price
- $8.53
- Shares after
- 360,616
- Date
- 01 Feb 2024
- Ownership
- Direct
- Footnotes
- F2
TVTX
transaction
Common Stock
Sale
- Transaction value
- $88,742
- Shares
- -10,016
- Change %
- -2.8%
- Price
- $8.86
- Shares after
- 350,600
- Date
- 01 Feb 2024
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TVTX
transaction
Derivative
Employee stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +360,000
- Change %
- Price
- $0.000000
- Shares after
- 360,000
- Date
- 31 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 360,000
- Exercise price
- $8.93
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer.
Footnote F2
Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
Footnote F3
This sale was made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
Footnote F4
One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.